Gland Pharma Q2 Results
- BSE: 543245
- NSE: GLAND
- ISIN: INE068V01023
- Sector: Biotechnology & Drugs
BSE
2,412.50
-71.85 (-2.89%)
-71.85 (-2.89%)Volume98.85 K
Updated: Wed 22 Jul, 2026 | 15:29:55
NSE
2,427.90-54.50 (-2.20%)
-54.50 (-2.20%)Volume6.71 L
Updated: Wed 22 Jul, 2026 | 15:30:04
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Gland Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,279.30 | 1,238.91 | 3.26% | 1,202.60 | 6.38% |
| Depreciation/ Amortization | 106.31 | 101.05 | 5.20% | 93.83 | 13.31% |
| Operating Income | 207.58 | 266.71 | -22.17% | 203.23 | 2.14% |
| Net Income | 183.68 | 215.48 | -14.76% | 163.53 | 12.32% |
| Other Operating Expenses Total | 183.98 | 163.03 | 12.85% | 158.13 | 16.35% |
| Net Income Before Taxes | 283.92 | 312.74 | -9.22% | 256.78 | 10.57% |
| Total Revenue | 1,486.88 | 1,505.62 | -1.25% | 1,405.83 | 5.76% |
| Selling/ General/ Admin Expenses Total | 385.03 | 408.04 | -5.64% | 375.19 | 2.62% |
| Diluted Normalized EPS | 11.15 | 13.08 | -14.76% | 9.93 | 12.29% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.